Dr. Mark Gonzalgo is professor and vice chair of urology, University of Miami Miller School of
Medicine and Executive Director of Perioperative Surgical Services, University of Miami Health
System. He also serves as director of the urologic oncology fellowship program. Dr. Gonzalgo is
a urologic oncologist with expertise in open and robotic surgical approaches for the treatment
of prostate, bladder, and kidney cancers. He received his undergraduate degree with honors
from the University of California at Berkeley and completed medical and graduate school at the
USC Keck School of Medicine. Dr. Gonzalgo completed his general surgery and urology training
at Johns Hopkins and a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer
Center. Dr. Gonzalgo is a recognized expert in DNA methylation and is particularly interested in
developing new diagnostic and therapeutic approaches for cancer detection and treatment. He
has carried out pioneering research on the molecular biology and early detection of prostate,
bladder, and kidney cancer and has published extensively on the scientific and clinical aspects
of these diseases. Dr. Gonzalgo has been recognized as a Top Doctor by US News & World
Report and is an emeritus member of the scientific advisory board of the Bladder Cancer
Advocacy Network (BCAN).
